Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Prostate-specific antigen is an androgen-responsive protein used in adult men as a marker of prostate disease; however, its physiological rise during male puberty is poorly described. We evaluated whether serum prostate-specific antigen may serve as a biomarker of pubertal development in healthy boys and established age-specific reference intervals. DESIGN: Longitudinal cohort study. METHODS: The study included 104 healthy boys and 890 serum samples from the Copenhagen Puberty Study II. Serum prostate-specific antigen was measured by commercial immunoassay. Age-specific reference intervals were developed using generalised additive models for location, scale and shape. Total testosterone and sex hormone-binding globulin were measured by immunoassay. Free testosterone was calculated using the Vermeulen equation. Pubertal onset defined as testicular volume > 3 mL. Boys were categorised by genital stage 1 to 5, and group differences were analysed using linear mixed models. RESULTS: Prostate-specific antigen increased from 12 years of age, reaching a median concentration of 0.46 µg/L at 16.5 years, with a reference interval of 0.19 - 0.93 µg/L (model-estimated median ±2 SD). It was undetectable in prepubertal boys and at pubertal onset. A significant increase was observed from genital stage 3, indicating that prostate-specific antigen rose after pubertal onset and later than testosterone. Thresholds of > 3.06 nmol/L for total testosterone and > 36 pmol/L for free testosterone predicted detectable prostate-specific antigen. CONCLUSION: Prostate-specific antigen increased with pubertal progression but was not detectable prior to the onset of puberty, suggesting that a threshold of androgen exposure is required for measurable production.
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,292
OpenAlex ID: W7236608013
